Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD

NCT03247517 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Placebo
DRUG: 200mg SPN-812
DRUG: 400mg SPN-812

Sponsor

Supernus Pharmaceuticals, Inc.